Pandemic 2009 H1N1 Influenza A Virus Carrying a Q136K Mutation in the Neuraminidase Gene Is Resistant to Zanamivir but Exhibits Reduced Fitness in the Guinea Pig Transmission Model

被引:20
作者
Kaminski, Michael M. [1 ]
Ohnemus, Annette [1 ]
Staeheli, Peter [1 ]
Rubbenstroth, Dennis [1 ]
机构
[1] Univ Freiburg, Dept Virol, D-79106 Freiburg, Germany
关键词
IN-VITRO; OSELTAMIVIR RESISTANCE; HEALTHY-VOLUNTEERS; A(H1N1) VIRUSES; ACTIVE-SITE; INHIBITORS; PHARMACOKINETICS; SENSITIVITY; VARIANTS; VIVO;
D O I
10.1128/JVI.02507-12
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Resistance of influenza A viruses to neuraminidase inhibitors can arise through mutations in the neuraminidase (NA) gene. We show here that a Q136K mutation in the NA of the 2009 pandemic H1N1 virus confers a high degree of resistance to zanamivir. Resistance is accompanied by reduced numbers of NA molecules in viral particles and reduced intrinsic enzymatic activity of mutant NA. Interestingly, the Q136K mutation strongly impairs viral fitness in the guinea pig transmission model.
引用
收藏
页码:1912 / 1915
页数:4
相关论文
共 37 条
[1]   Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance [J].
Bloom, Jesse D. ;
Gong, Lizhi Ian ;
Baltimore, David .
SCIENCE, 2010, 328 (5983) :1272-1275
[2]   Safety, Tolerability, and Pharmacokinetics of Intravenous Oseltamivir: Single- and Multiple-Dose Phase I Studies with Healthy Volunteers [J].
Brennan, Barbara J. ;
Davies, Brian ;
Cirrincione-Dall, Georgina ;
Morcos, Peter N. ;
Beryozkina, Anna ;
Chappey, Colombe ;
Baldo, Pau Aceves ;
Lennon-Chrimes, Sian ;
Rayner, Craig R. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (09) :4729-4737
[3]   Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo [J].
Carr, J ;
Ives, J ;
Kelly, L ;
Lambkin, R ;
Oxford, J ;
Mendel, D ;
Tai, L ;
Roberts, N .
ANTIVIRAL RESEARCH, 2002, 54 (02) :79-88
[4]   Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers [J].
Cass, LMR ;
Efthymiopoulos, C ;
Bye, A .
CLINICAL PHARMACOKINETICS, 1999, 36 (Suppl 1) :1-11
[5]   Antiviral agents active against influenza A viruses [J].
De Clercq, Erik .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (12) :1015-1025
[6]   Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States [J].
Dharan, Nila J. ;
Gubareva, Larisa V. ;
Meyer, John J. ;
Okomo-Adhiambo, Margaret ;
McClinton, Reginald C. ;
Marshall, Steven A. ;
George, Kirsten St. ;
Epperson, Scott ;
Brammer, Lynnette ;
Klimov, Alexander I. ;
Bresee, Joseph S. ;
Fry, Alicia M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (10) :1034-1041
[7]   Oseltamivir-Resistant Pandemic H1N1/2009 Influenza Virus Possesses Lower Transmissibility and Fitness in Ferrets [J].
Duan, Susu ;
Boltz, David A. ;
Seiler, Patrick ;
Li, Jiang ;
Bragstad, Karoline ;
Nielsen, Lars P. ;
Webby, Richard J. ;
Webster, Robert G. ;
Govorkova, Elena A. .
PLOS PATHOGENS, 2010, 6 (07) :1-10
[8]   Use of Intravenous Zanamivir after Development of Oseltamivir Resistance in a Critically Ill Immunosuppressed Child Infected with 2009 Pandemic Influenza A (H1N1) Virus [J].
Dulek, Daniel E. ;
Williams, John V. ;
Creech, C. Buddy ;
Schulert, Alynna K. ;
Frangoul, Haydar A. ;
Domm, Jennifer ;
Denison, Mark R. ;
Chappell, James D. .
CLINICAL INFECTIOUS DISEASES, 2010, 50 (11) :1493-1496
[9]   Severe H1N1-Associated Acute Respiratory Failure in Immunocompromised Children [J].
Elbahlawan, Lama ;
Gaur, Aditya H. ;
Furman, Wayne ;
Jeha, Sima ;
Woods, Tina ;
Norris, Angela ;
Morrison, R. Ray .
PEDIATRIC BLOOD & CANCER, 2011, 57 (04) :625-628
[10]   Intravenous Zanamivir for Oseltamivir-Resistant 2009 H1N1 Influenza [J].
Gaur, Aditya H. ;
Bagga, Bindiya ;
Barman, Subrata ;
Hayden, Randall ;
Lamptey, Aubrey ;
Hoffman, James M. ;
Bhojwani, Deepa ;
Flynn, Patricia M. ;
Tuomanen, Elaine ;
Webby, Richard .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (01) :88-89